Group One Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-150
| Closed | -$423 | – | 7661 |
|
|
2024
Q1 | $423 | Hold |
150
| – | – | ﹤0.01% | 6757 |
|
|
2023
Q4 | $470 | Hold |
150
| – | – | ﹤0.01% | 7099 |
|
|
2023
Q3 | $495 | Hold |
150
| – | – | ﹤0.01% | 7342 |
|
|
2023
Q2 | $495 | Hold |
150
| – | – | ﹤0.01% | 7371 |
|
|
2023
Q1 | $509 | Hold |
150
| – | – | ﹤0.01% | 6906 |
|
|
2022
Q4 | $542 | Hold |
150
| – | – | ﹤0.01% | 6936 |
|
|
2022
Q3 | $1K | Hold |
150
| – | – | ﹤0.01% | 7402 |
|
|
2022
Q2 | $1K | Hold |
150
| – | – | ﹤0.01% | 7655 |
|
|
2022
Q1 | $1K | Hold |
150
| – | – | ﹤0.01% | 7903 |
|
|
2021
Q4 | $1K | Hold |
150
| – | – | ﹤0.01% | 8053 |
|
|
2021
Q3 | $1K | Hold |
150
| – | – | ﹤0.01% | 8056 |
|
|
2021
Q2 | $1K | Hold |
150
| – | – | ﹤0.01% | 8045 |
|
|
2021
Q1 | $2K | Hold |
150
| – | – | ﹤0.01% | 7414 |
|
|
2020
Q4 | $5K | Buy |
+150
| New | +$2.59K | ﹤0.01% | 6047 |
|
|
2020
Q3 | – | Sell |
-5,197
| Closed | -$86K | – | 6633 |
|
|
2020
Q2 | $86K | Buy |
5,197
+422
| +9% | +$5.03K | ﹤0.01% | 4027 |
|
|
2020
Q1 | $41K | Buy |
+4,775
| New | +$66.7K | ﹤0.01% | 3848 |
|
|
2019
Q4 | – | Sell |
-6,830
| Closed | -$97.4K | – | 5729 |
|
|
2019
Q3 | $98K | Buy |
6,830
+6,176
| +944% | +$90.6K | ﹤0.01% | 3575 |
|
|
2019
Q2 | $9K | Buy |
654
+650
| +16,250% | +$9.82K | ﹤0.01% | 4466 |
|
|
2019
Q1 | $0 | Sell |
4
-945
| -100% | -$14.1K | ﹤0.01% | 5475 |
|
|
2018
Q4 | $13K | Buy |
+949
| New | +$16.7K | ﹤0.01% | 4186 |
|
|
2018
Q3 | – | Sell |
-3,953
| Closed | -$120K | – | 5691 |
|
|
2018
Q2 | $169K | Buy |
3,953
+2,105
| +114% | +$96.4K | ﹤0.01% | 3185 |
|
|
2018
Q1 | $121K | Buy |
1,848
+114
| +7% | +$8.08K | ﹤0.01% | 3132 |
|
|
2017
Q4 | $127K | Buy |
+1,734
| New | +$143K | ﹤0.01% | 3216 |
|
|
2017
Q3 | – | Sell |
-2,632
| Closed | -$202K | – | 5244 |
|
|
2017
Q2 | $174K | Sell |
2,632
-647
| -20% | -$80.1K | ﹤0.01% | 2740 |
|
|
2017
Q1 | $711K | Buy |
3,279
+1,648
| +101% | +$235K | 0.01% | 1595 |
|
|
2016
Q4 | $151K | Buy |
+1,631
| New | +$184K | ﹤0.01% | 2603 |
|
|
2016
Q2 | – | Sell |
-4,589
| Closed | -$569K | – | 5010 |
|
|
2016
Q1 | $752K | Sell |
4,589
-485
| -10% | -$98.3K | 0.01% | 1392 |
|
|
2015
Q4 | $1.66M | Sell |
5,074
-1,097
| -18% | -$357K | 0.02% | 984 |
|
|
2015
Q3 | $1.99M | Buy |
6,171
+2,871
| +87% | +$1.26M | 0.03% | 788 |
|
|
2015
Q2 | $1.31M | Sell |
3,300
-3,514
| -52% | -$1.49M | 0.02% | 1017 |
|
|
2015
Q1 | $3.35M | Buy |
6,814
+462
| +7% | +$179K | 0.05% | 398 |
|
|
2014
Q4 | $2.27M | Buy |
6,352
+2,812
| +79% | +$837K | 0.03% | 587 |
|
|
2014
Q3 | $682K | Buy |
3,540
+504
| +17% | +$111K | 0.01% | 1383 |
|
|
2014
Q2 | $725K | Sell |
3,036
-5,147
| -63% | -$1.05M | 0.01% | 1361 |
|
|
2014
Q1 | $2.09M | Sell |
8,183
-894
| -10% | -$273K | 0.04% | 601 |
|
|
2013
Q4 | $1.8M | Buy |
+9,077
| New | +$1.61M | 0.03% | 709 |
|
Other funds holding LUMO
AI
JFG
LPC
GWM
Group One Trading's LUMO Position: Q2 2024 in Review
Group One Trading sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2024, closing a stake of 150 shares — an estimated $423 sold.
Group One Trading first reported a position in LUMO in Q4 2013 and held it in 36 quarters. The position peaked at $3.35M in Q1 2015. 35 funds tracked by Wall St. Rank hold LUMO as of Q2 2024.
- Group One Trading reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Group One Trading sold 150 Lumos Pharma, Inc. Common Stock shares in Q2 2024, an estimated $423.
- Group One Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 36 quarters.
- Group One Trading's Lumos Pharma, Inc. Common Stock position peaked at $3.35M in Q1 2015.
- 35 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2024.
Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.